• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素化患者中抗凝血酶III浓缩物的消除动力学。

Kinetics of elimination of antithrombin III concentrate in heparinized patients.

作者信息

Marciniak E, Gockerman J P

出版信息

Br J Haematol. 1981 Aug;48(4):617-25. doi: 10.1111/j.1365-2141.1981.00617.x.

DOI:10.1111/j.1365-2141.1981.00617.x
PMID:7272219
Abstract

The rate of elimination of injected antithrombin III (AT III) concentrate was investigated by measuring plasma AT III levels in two control subjects and four patients treated with continuous intravenous infusion of heparin. No significant differences were noted in the disappearance rate of injected AT III between controls and patients receiving heparin for several days. Their half-time of AT III elimination was 8.4--13.6 h. The patient in whom AT III concentrate was injected at the start of heparin therapy showed a very rapid decrease of AT III activity with a three-fold increase in the elimination rate constant. Inactive, modified AT III protein present in purified AT III concentrate was found in the circulation of all injected patients. No evidence was obtained that this altered AT III was eliminated more rapidly than the unaltered AT III or that it was subjected to accelerated clearance during heparin therapy.

摘要

通过测量两名对照受试者和四名接受肝素持续静脉输注治疗的患者的血浆抗凝血酶III(AT III)水平,研究了注射用AT III浓缩物的消除速率。在对照者和接受肝素治疗数天的患者之间,注射用AT III的消失速率未发现显著差异。其AT III消除半衰期为8.4 - 13.6小时。在肝素治疗开始时注射AT III浓缩物的患者,其AT III活性迅速下降,消除速率常数增加了三倍。在所有注射患者的循环中均发现纯化的AT III浓缩物中存在无活性的、修饰的AT III蛋白。没有证据表明这种改变的AT III比未改变的AT III消除得更快,或者在肝素治疗期间其清除加速。

相似文献

1
Kinetics of elimination of antithrombin III concentrate in heparinized patients.肝素化患者中抗凝血酶III浓缩物的消除动力学。
Br J Haematol. 1981 Aug;48(4):617-25. doi: 10.1111/j.1365-2141.1981.00617.x.
2
Studies of the heterogeneity of antithrombin III concentrates.
Br J Haematol. 1983 Sep;55(1):37-46. doi: 10.1111/j.1365-2141.1983.tb01222.x.
3
Heparin-antithrombin III binding. In vitro and in vivo studies.肝素-抗凝血酶III结合:体外和体内研究
Haemostasis. 1979;8(6):373-89. doi: 10.1159/000214328.
4
Treatment of congenital antithrombin III deficiency with concentrates.
Br J Haematol. 1982 Mar;50(3):531-5. doi: 10.1111/j.1365-2141.1982.tb01949.x.
5
[Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
Hokkaido Igaku Zasshi. 1987 Jan;62(1):108-21.
6
Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.抗凝血酶III浓缩物:其在健康状态及抗凝血酶III缺乏症中的分解代谢
Scand J Clin Lab Invest. 1981 Sep;41(5):469-77. doi: 10.3109/00365518109090485.
7
Catabolism and distribution of functionally heterogeneous human antithrombin III.
J Lab Clin Med. 1987 Jan;109(1):89-96.
8
[Study of serum level of antithrombin-III antigen, antithrombin activity, and its ratio of AT-III-heparin complex formation in maintenance hemodialysis patients].维持性血液透析患者抗凝血酶III抗原血清水平、抗凝血酶活性及其AT-III-肝素复合物形成比率的研究
Nihon Jinzo Gakkai Shi. 1989 Nov;31(11):1171-7.
9
Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.凝血酶结合受损的遗传性异常抗凝血酶III的纯化与特性分析
J Lab Clin Med. 1984 Aug;104(2):245-56.
10
Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.抗凝血酶III缺乏症:一种生化性质正常的分子合成减少。
Blood. 1982 Jul;60(1):78-83.

引用本文的文献

1
Plasma elimination of antithrombin III (heparin cofactor activity) is accelerated in term newborn infants.
Eur J Pediatr. 1984 Feb;141(4):225-7. doi: 10.1007/BF00572765.
2
Antithrombin III activity (residual thrombin activity) in plasma from non-medicated or heparinized horses.来自未用药或肝素化马匹的血浆中的抗凝血酶III活性(残余凝血酶活性)。
Vet Res Commun. 1989;13(1):31-46. doi: 10.1007/BF00366851.